Page results
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Bones marrow harvest patient information page.
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Information about staff who work in the Macmillan Support and Information Service.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This is information for women who have been given a diagnosis of adenomyosis.
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
File results
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0007 - Outpatient activity for 2022